REVIEW article
Front. Neurosci.
Sec. Neuropharmacology
Volume 19 - 2025 | doi: 10.3389/fnins.2025.1690170
The multi-pathway treatment of flavonoids as natural compounds in neurological diseases: achievements, limitations, and prospects
Provisionally accepted
- Chengde Medical University, Chengde, China
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Background: The nervous system governs fundamental life activities and higher neural functions, maintaining the body's interaction with the external environment and internal homeostasis. Neurological diseases are a common and complex group of disorders that severely impair patients' quality of life and physical health. Flavonoids, as a class of active components widely present in natural plants, play a crucial role in the research on neurological diseases. Objective: The purpose of this review is to systematically sum up the action mechanisms, research advancements, and existing clinical uses of flavonoids in preventing and treating neurological diseases, probing into their potential in the management of neurological diseases. Methods: By searching databases including PubMed, Web of Science, Embase, Wiley, Springer, NPG, ACS, Elsevier, and RSC, literature published between 2000 and 2025 concerning the treatment of neurological diseases with flavonoids was collected from both domestic and international sources. Priority should be given to flavonoids that have been confirmed by existing studies to be directly related to the pathogenesis or intervention effect of neurological diseases, with high quality and no contradictory results, clear chemical structures and definite metabolic pathways in vivo. Flavonoids that have no clear neurological association, have only been reported once and lack repeated verification or have a low level of evidence, and whose structures have not been resolved or whose metabolic processes are ambiguous should be excluded. After excluding studies with duplicate components and mechanisms, as well as outdated ones, a total of 190 core studies were finally screened and included from more than 15,000 literatures. These were systematically organised, categorised, and analysed across five dimensions: types of flavonoids, disease categories, experimental models, regulatory effects, and key targets. Results: Flavonoids can exert neuroprotective effects in the prevention and treatment of neurological diseases through multiple pathways, such as anti-inflammation, anti-oxidation, anti-apoptosis, and neurotransmitter regulation. Conclusion: Flavonoids exhibit clear pharmacological effects and favorable safety profiles in the prevention and treatment of neurological diseases, laying a foundation for the research and development of new drugs.
Keywords: Flavonoids, Neurological Diseases, Neuroprotection, anti-inflammatory, Antioxidation
Received: 21 Aug 2025; Accepted: 21 Oct 2025.
Copyright: © 2025 Fan, Lian, Zhang, Ren, Liu, Meng and Zhang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Lin Zhang, zhangliner_123@cdmc.edu.cn
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.